Detection of Prostate Cancer With Magnetic Resonance Imaging: Optimization of T1-Weighted, T2-Weighted, Dynamic-Enhanced T1-Weighted, Diffusion-Weighted Imaging Apparent Diffusion Coefficient Mapping Sequences and MR Spectroscopy, Correlated With Biopsy and Histopathological Findings

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of computer assisted tomography

• Publication date

  2012-01-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1097/RCT.0b013e31823f6263PMID 22261768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diffusion weighted imaging in prostate cancer

  2011cited by this paper
• Magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer : initial experience *

  2009cited by this paper
• Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer.

  2009cited by this paper
• Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.

  2009cited by this paper
• Espectroscopia por ressonância magnética no diagnóstico do câncer de próstata: experiência inicial

  2009cited by this paper
• Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.

  2009cited by this paper
• Imaging localized prostate cancer: current approaches and new developments.

  2009influential reference
• Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging.

  2008cited by this paper
• Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.

  2008cited by this paper
• Advances in MR spectroscopy of the prostate.

  2008cited by this paper
• Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.

  2008cited by this paper
• A Meta-Analysis of the Accuracy of Prostate Cancer Studies Which Use Magnetic Resonance Spectroscopy as a Diagnostic Tool

  2008cited by this paper
• Diffusion-Weighted Imaging of the Prostate at 3 T for Differentiation of Malignant and Benign Tissue in Transition and Peripheral Zones: Preliminary Results

  2007cited by this paper
• Imaging prostate cancer: a multidisciplinary perspective.

  2007cited by this paper
• Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.

  2007cited by this paper
• Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.

  2007cited by this paper
• Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.

  2007cited by this paper
• Impact of Additional Sampling in the TRUS-Guided Biopsy for the Diagnosis of Prostate Cancer

  2007cited by this paper
• Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.

  2006cited by this paper
• Combined MRI and MR spectroscopy of the prostate before radical prostatectomy.

  2006cited by this paper
• Original contributions Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level

  2006cited by this paper
• Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy.

  2006cited by this paper
• Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.

  2006cited by this paper
• MR imaging and MR spectroscopy in prostate cancer management.

  2006cited by this paper
• Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer.

  2005cited by this paper
• Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.

  2005cited by this paper
• Diffusion-Weighted Imaging of Prostate Cancer

  2005cited by this paper
• MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.

  2005cited by this paper
• Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.

  2004cited by this paper
• Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.

  2004cited by this paper
• Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging.

  2004cited by this paper
• Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.

  2003cited by this paper
• Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer

  2002cited by this paper
• Single‐voxel oversampled J‐resolved spectroscopy of in vivo human prostate tissue

  2001cited by this paper
• Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study.

  2001cited by this paper
• Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging

  2000cited by this paper
• Proton MR spectroscopy of prostatic tissue focused on the etection of spermine, a possible biomarker of malignant behavior in prostate cancer

  2000cited by this paper
• Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.

  1999cited by this paper
• Quantitative 3D VUSE pulmonary MRA.

  1999cited by this paper
• Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer.

  1998cited by this paper
• Population-based study of long-term survival in patients with clinically localised prostate cancer.

  1997cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper

• Multi-view radiomics and deep learning modeling for prostate cancer detection based on multi-parametric MRI

  2023cites this paper
• IMAGING AND HISTOPATHOLOGICAL CORRELATION OF PROSTATIC LESIONS

  2022cites this paper
• Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging

  2022cites this paper
• Evaluation of Prostatic Lesions by Transrectal Ultrasonography, Colour Doppler and TRUS-Guided Biopsy

  2021cites this paper
• Accuracy of Magnetic Resonance Spectroscopy Techniques in Prostate Cancer and Prostatitis.

  2020cites this paper
• Massive subchorionic hematoma (Breus’ mole) presents a variety of ultrasonic appearances: A case report and literature review

  2019cites this paper
• Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) as a Diagnostic Method for Prostate Cancer

  2018cites this paper
• Modelling human prostate cancer: Rat models

  2018cites this paper
• Image Guidance Systems for Brachytherapy

  2017cites this paper
• Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.

  2017cites this paper
• Accuracy of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate cancer: systematic review and meta-analysis

  2017cites this paper
• Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness

  2017cites this paper
• Impact of an endorectal coil for 1H-magnetic resonance spectroscopy of the prostate at 3.0T in comparison to 1.5T: Do we need an endorectal coil?

  2016cites this paper
• Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy

  2016cites this paper
• Clinical Imaging of Tumor Metabolism with ¹H Magnetic Resonance Spectroscopy.

  2016cites this paper
• Image-guided high-dose-rate brachytherapy boost to the dominant intraprostatic lesion using multiparametric magnetic resonance imaging including spectroscopy: Results of a prospective study.

  2016cites this paper
• Prostate Cancer Magnetic Resonance Spectroscopy Imaging at 1.5 and 3.0 T

  2016cites this paper
• Chapter 11 – Imaging in Localized Prostate Cancer

  2016cites this paper
• Comparison of high-resolution T1W 3D GRE (LAVA) with 2-point Dixon fat/water separation (FLEX) to T1W fast spin echo (FSE) in prostate cancer (PCa).

  2016cites this paper
• Contrast enhancement by combining T1‐ and T2‐weighted structural brain MR Images

  2015cites this paper
• Overview of current multiparametric magnetic resonance imaging approach in the diagnosis and staging of prostate cancer

  2015cites this paper
• Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

  2015cites this paper
• Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities – a radiologist's perspective

  2014cites this paper
• [Optimization of follow up in prostate cancer active surveillance].

  2014cites this paper
• The role of diffusion weighted MR imaging in the diagnosis of acute pancreatitis.

  2014influential citation
• Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices

  2014cites this paper
• Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens

  2014cites this paper
• Underestimated role of MRI in EAU guidelines on prostate cancer.

  2014cites this paper
• The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis

  2014cites this paper
• Multiparametric magnetic resonance imaging-ultrasound fusion-guided prostate biopsy: role in diagnosis and management of prostatic cancer.

  2014cites this paper
• Meta-analysis of Diffusion-Weighted Magnetic Resonance Imaging in Detecting Prostate Cancer

  2013cites this paper
• A brief review of the combined use of T2-weighted MRI and diffusion-weighted imaging for prostate cancer diagnosis.

  2013cites this paper
• The efficacy of diffusion weighted imaging and apparent diffusion coefficient mapping for meniscal tears in the knee

  2013cites this paper
• 18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients

  2013cites this paper
• Limitations, disabilities, and pitfalls of dynamic contrast-enhanced MRI as a diagnostic modality in prostate cancer.

  2013cites this paper
• The Feasibility of Multiparametric Magnetic Resonance Imaging for Targeted Biopsy Using Novel Navigation Systems to Detect Early Stage Prostate Cancer: The Preliminary Experience

  2013cites this paper
• Identification and Localization of Prostate Cancer with Combined Use of T2-Weighted, Diffusion Weighted MRI and Proton MR Spectroscopy, Correlation with Histopathology

  2013cites this paper
• Ultra‐high b‐value diffusion‐weighted MRI for the detection of prostate cancer with 3‐T MRI

  2013cites this paper